217 related articles for article (PubMed ID: 14529420)
41. A mucosal vaccine against diphtheria: formulation of cross reacting material (CRM(197)) of diphtheria toxin with chitosan enhances local and systemic antibody and Th2 responses following nasal delivery.
McNeela EA; O'Connor D; Jabbal-Gill I; Illum L; Davis SS; Pizza M; Peppoloni S; Rappuoli R; Mills KH
Vaccine; 2000 Dec; 19(9-10):1188-98. PubMed ID: 11137256
[TBL] [Abstract][Full Text] [Related]
42. Trimethylated chitosan as polymeric absorption enhancer for improved peroral delivery of peptide drugs.
van der Merwe SM; Verhoef JC; Verheijden JH; Kotzé AF; Junginger HE
Eur J Pharm Biopharm; 2004 Sep; 58(2):225-35. PubMed ID: 15296951
[TBL] [Abstract][Full Text] [Related]
43. In vitro evaluation of the viscoelastic properties of chitosan-thioglycolic acid conjugates.
Hornof MD; Kast CE; Bernkop-Schnürch A
Eur J Pharm Biopharm; 2003 Mar; 55(2):185-90. PubMed ID: 12637095
[TBL] [Abstract][Full Text] [Related]
44. Porous chitosan scaffold containing microspheres loaded with transforming growth factor-beta1: implications for cartilage tissue engineering.
Kim SE; Park JH; Cho YW; Chung H; Jeong SY; Lee EB; Kwon IC
J Control Release; 2003 Sep; 91(3):365-74. PubMed ID: 12932714
[TBL] [Abstract][Full Text] [Related]
45. Chitosan: properties, preparations and application to microparticulate systems.
Kaş HS
J Microencapsul; 1997; 14(6):689-711. PubMed ID: 9394251
[TBL] [Abstract][Full Text] [Related]
46. Preparation and evaluation of sustained release cross-linked chitosan microspheres containing phenobarbitone.
al-Helw AA; Al-Angary AA; Mahrous GM; al-Dardari MM
J Microencapsul; 1998; 15(3):373-82. PubMed ID: 9608399
[TBL] [Abstract][Full Text] [Related]
47. Chitosan for mucosal vaccination.
van der Lubben IM; Verhoef JC; Borchard G; Junginger HE
Adv Drug Deliv Rev; 2001 Nov; 52(2):139-44. PubMed ID: 11718937
[TBL] [Abstract][Full Text] [Related]
48. Chitosan matrix for oral sustained delivery of ampicillin.
Chandy T; Sharma CP
Biomaterials; 1993 Oct; 14(12):939-44. PubMed ID: 8268386
[TBL] [Abstract][Full Text] [Related]
49. Uptake and cytotoxicity of chitosan molecules and nanoparticles: effects of molecular weight and degree of deacetylation.
Huang M; Khor E; Lim LY
Pharm Res; 2004 Feb; 21(2):344-53. PubMed ID: 15032318
[TBL] [Abstract][Full Text] [Related]
50. Gadolinium neutron-capture therapy using novel gadopentetic acid-chitosan complex nanoparticles: in vivo growth suppression of experimental melanoma solid tumor.
Tokumitsu H; Hiratsuka J; Sakurai Y; Kobayashi T; Ichikawa H; Fukumori Y
Cancer Lett; 2000 Mar; 150(2):177-82. PubMed ID: 10704740
[TBL] [Abstract][Full Text] [Related]
51. Preparation and characterization of melatonin-loaded stearyl alcohol microspheres.
Lee BJ; Choe JS; Kim CK
J Microencapsul; 1998; 15(6):775-87. PubMed ID: 9818955
[TBL] [Abstract][Full Text] [Related]
52. Release phenomena of insulin from an implantable device composed of a polyion complex of chitosan and sodium hyaluronate.
Surini S; Akiyama H; Morishita M; Nagai T; Takayama K
J Control Release; 2003 Jul; 90(3):291-301. PubMed ID: 12880696
[TBL] [Abstract][Full Text] [Related]
53. Chitosan and its derivatives in mucosal drug and vaccine delivery.
van der Lubben IM; Verhoef JC; Borchard G; Junginger HE
Eur J Pharm Sci; 2001 Oct; 14(3):201-7. PubMed ID: 11576824
[TBL] [Abstract][Full Text] [Related]
54. Preparation and characterization of chitosan microparticles intended for controlled drug delivery.
Ko JA; Park HJ; Hwang SJ; Park JB; Lee JS
Int J Pharm; 2002 Dec; 249(1-2):165-74. PubMed ID: 12433445
[TBL] [Abstract][Full Text] [Related]
55. [Preparation and properties of 5-fluorouracil-loaded chitosan microspheres for the intranasal administration].
Zheng AP; Yu SY; Zhao Y; Wu FL
Beijing Da Xue Xue Bao Yi Xue Ban; 2004 Jun; 36(3):300-4. PubMed ID: 15205705
[TBL] [Abstract][Full Text] [Related]
56. Co-encapsulation of two plasmids in chitosan microspheres as a non-viral gene delivery vehicle.
Ozbas-Turan S; Aral C; Kabasakal L; Keyer-Uysal M; Akbuga J
J Pharm Pharm Sci; 2003; 6(1):27-32. PubMed ID: 12753728
[TBL] [Abstract][Full Text] [Related]
57. Sustained-release of oxytetracycline from chitosan microspheres prepared by interfacial acylation and spray hardening methods.
Mi FL; Wong TB; Shyu SS
J Microencapsul; 1997; 14(5):577-91. PubMed ID: 9292434
[TBL] [Abstract][Full Text] [Related]
58. Chitosan: some pharmaceutical and biological aspects--an update.
Singla AK; Chawla M
J Pharm Pharmacol; 2001 Aug; 53(8):1047-67. PubMed ID: 11518015
[TBL] [Abstract][Full Text] [Related]
59. Effect of magnesium stearate on chitosan microspheres prepared by an emulsification-coacervation technique.
Lim LY; Wan LS
J Microencapsul; 1998; 15(3):319-33. PubMed ID: 9608395
[TBL] [Abstract][Full Text] [Related]
60. Preparation of gadopentetic acid-loaded chitosan microparticles for gadolinium neutron-capture therapy of cancer by a novel emulsion-droplet coalescence technique.
Tokumitsu H; Ichikawa H; Fukumori Y; Block LH
Chem Pharm Bull (Tokyo); 1999 Jun; 47(6):838-42. PubMed ID: 10399838
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
